Life Insurance Critical Illness Income Protection

How life, CI and IP layer against each other

The three products are sometimes presented as a ladder, which undersells the structural difference between them. Life cover pays a lump sum on death; CI cover pays a lump sum on diagnosis; income protection pays a monthly benefit while the insured is unable to work and continues until recovery, retirement, or end of term. These are three distinct cashflow shapes, not three stages of the same product.

A triple-product arrangement is not "all the protection you could possibly want" — it is a specific response to the three most likely income-replacement failures during a working life. Households without dependants or a mortgage may need none of the three; households with both a mortgage and dependants usually need some combination of all three, with the exact sizing depending on existing employer cover and savings.

What "critical illness" means inside the policy

A UK critical illness policy is a closed list of conditions, not an open diagnosis product. The schedule enumerates named illnesses — typically 40 to 70, depending on the insurer — each with its own clinical severity definition drawn from (or tightened beyond) the ABI's model wording. If the medical diagnosis falls outside one of those definitions, the policy pays nothing, regardless of how serious the illness actually is.

The difference between a strong and weak CI policy often isn't visible in the condition count — it's visible in the severity wording. A policy listing 70 conditions with tight wording on the top three drivers of claims can be worse in practice than a 50-condition policy with generous cancer and heart-attack definitions. Condition counts are a headline metric; severity thresholds are the actual product.

What the CI claims statistics show

The main reasons CI claims do not pay in full are: (1) the diagnosis does not meet the severity definition on the schedule, so the claim is paid partially instead; (2) the condition is not on the policy's list at all; (3) non-disclosure at application. Outright declines on non-disclosure grounds are rarer than partial payments on severity grounds — a distinction worth keeping in mind when reading claims statistics.

Speed of claim settlement on CI is driven by how cleanly the diagnosis maps to the schedule. Cancer claims with histology reports showing invasive disease pay quickly; heart-attack claims with clear troponin curves pay quickly; stroke claims with imaging and lasting neurological deficit pay quickly. Where the medical facts don't map cleanly to the ABI wording, insurers have to commission independent reports, and those reports can add months to the timeline even when the eventual answer is a full payment.

The cost drivers on UK critical illness cover

A large part of the CI premium variation between UK insurers is medical-underwriting judgement rather than headline rate. Two insurers with identical list prices on a 35-year-old non-smoker can produce quotes 40% apart once a past history of anxiety, a single raised blood pressure reading, or a family history of colorectal cancer is declared. Price comparison on CI is more meaningful after underwriting than before.

Where UK CI pricing varies most between insurers is on the severity wording behind the list, not the list itself. A cheaper CI quote that tightens cancer or heart-attack definitions pays out less often; a more expensive CI quote with broader severity thresholds pays out on a wider set of real-world diagnoses. The right way to read a CI quote is premium alongside the schedule, not premium on its own.

A concrete case

Consider a self-employed 42-year-old with £250,000 life cover, £100,000 CI cover and £2,500/month income protection with an 8-week deferred period. Year 6, a listed stroke at ABI severity triggers both the CI policy (£100,000 lump sum) and the income protection policy (monthly benefit until return-to-work). Life cover continues in force for a future death claim. Three triggers, three separate payouts, three separate policies — which is the advantage of the triple structure over a single bundled product.